NPT Co (TSE:311A) Cash Conversion Cycle: 0.00 (As of Oct. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:311A NPT Co Ltd TSE:311A
9 GF Score
Price 円700.00
! 2 Warning Signs
View Full Analysis

What is NPT Co Cash Conversion Cycle?

NPT Co TSE:311A 9 Cash Conversion Cycle is 0.00 as of Oct. 2025. GuruFocus rates TSE:311A with a GF Score™ of 9/100. The stock has 2 warning signs investors should review.

Cash Conversion Cycle is one of several measures of management effectiveness. It equals Days Sales Outstanding + Days Inventory - Days Payable.

NPT Co's Days Sales Outstanding for the six months ended in Oct. 2025 was .
NPT Co's Days Inventory for the six months ended in Oct. 2025 was .
NPT Co's Days Payable for the six months ended in Oct. 2025 was .
Therefore, NPT Co's Cash Conversion Cycle (CCC) for the six months ended in Oct. 2025 was 0.00.

NPT Co  (TSE:311A) Cash Conversion Cycle Explanation

Generally, the lower this number is, the better for the company. Although it should be combined with other metrics (such as ROE % and ROA %), it can be especially useful for comparing close competitors, because the company with the lowest CCC is often the one with better management.

Be Aware

CCC is most effective with retail-type companies, which have inventories that are sold to customers. Consulting businesses, software companies and insurance companies are all examples of companies for whom this metric is meaningless.

The CCC is one of several tools that can help you evaluate management, especially if it is calculated for several consecutive time periods and for several competitors. Decreasing or steady CCCs are good, while rising ones should motivate you to dig a bit deeper.

NPT Co Cash Conversion Cycle Related Terms

NPT Co Cash Conversion Cycle Historical Data

* Premium members only.

The historical data trend for NPT Co's Cash Conversion Cycle can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NPT Co Cash Conversion Cycle Chart

NPT Co Annual Data
Trend Oct22 Oct23 Oct24 Oct25
Cash Conversion Cycle
0.00 0.00 0.00 0.00

NPT Co Semi-Annual Data
Oct22 Oct23 Apr24 Oct24 Apr25 Oct25 Apr26
Cash Conversion Cycle Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

TSE:311A vs ZTS, UTHR: Cash Conversion Cycle Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, NPT Co's Cash Conversion Cycle, along with its competitors' market caps and Cash Conversion Cycle data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

NPT Co Cash Conversion Cycle vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, NPT Co's Cash Conversion Cycle distribution charts can be found below:

* The bar in red indicates where NPT Co's Cash Conversion Cycle falls into.


TSE:311A
9GF Score
NPT Co Ltd TSE:311A
Cash Conversion Cycle is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

NPT Co Cash Conversion Cycle Calculation

Cash Conversion Cycle (CCC) measures how fast a company can convert cash on hand into even more cash on hand. This metric looks at the amount of time needed to sell inventory, the amount of time needed to collect receivables and the length of time the company is afforded to pay its bills without incurring penalties.

Cash Conversion Cycle is one of several measures of management effectiveness.

NPT Co's Cash Conversion Cycle for the fiscal year that ended in Oct. 2025 is calculated as

Cash Conversion Cycle=Days Sales Outstanding +Days Inventory-Days Payable
=+-
=0.00

NPT Co's Cash Conversion Cycle for the quarter that ended in Oct. 2025 is calculated as:

Cash Conversion Cycle=Days Sales Outstanding+Days Inventory-Days Payable
=+-
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Cash Conversion Cycle →
What does a Cash Conversion Cycle of 0.00 mean?
NPT Co (TSE:311A) has a Cash Conversion Cycle of 0.00 as of Oct. 2025. Cash conversion cycle equals sum of days inventory and days sales outstanding less days payable. View historical data on NPT Co and its competitors.
Is NPT Co's Cash Conversion Cycle too high?
NPT Co's current Cash Conversion Cycle is 0.00. Overall, NPT Co has a GF Score™ of 9/100, reflecting its overall financial health beyond just this single metric.
How does NPT Co's Cash Conversion Cycle compare to ZTS and UTHR?
NPT Co's Cash Conversion Cycle of 0.00 can be compared against companies in the Drug Manufacturers industry. The industry median Cash Conversion Cycle is 145.92. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Conversion Cycle for a Drug Manufacturers company?
The median Cash Conversion Cycle among Drug Manufacturers companies is 145.92, based on 955 companies in the industry. Companies in the top quartile (top 25%) have a Cash Conversion Cycle significantly above this median, while those in the bottom quartile fall well below. However, Cash Conversion Cycle should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Conversion Cycle mean?
A high Cash Conversion Cycle can signal that a stock is expensive relative to its fundamentals. Cash conversion cycle equals sum of days inventory and days sales outstanding less days payable. View historical data on NPT Co and its competitors. For the Drug Manufacturers industry, the median Cash Conversion Cycle is 145.92 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. NPT Co's current Cash Conversion Cycle is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NPT Co stock overvalued right now?
NPT Co (TSE:311A) has a current Cash Conversion Cycle of 0.00. The current Cash Conversion Cycle is 0.00. NPT Co's overall GF Score™ is 9/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Conversion Cycle calculated?
Cash Conversion Cycle is calculated from a company's financial statements. For NPT Co (TSE:311A), the current Cash Conversion Cycle is 0.00 as of Oct. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

NPT Co Business Description

Address 3-5-7 Ariake, Room 9, 16th floor, TOC Ariake East Tower, Koto-ku, Tokyo, JPN, 135-0063
NPT Co Ltd is engaged in the Clinical development of new drugs and treatments for personalized medicine.
9GF Score

Get the complete analysis for TSE:311A

Cash Conversion Cycle is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円700.00
Price